Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women

Clinical and Vaccine Immunology

Volumn 14, Issue 3, 2007, Pages 239-243

  Lefevre Pettazzoni, M ^a   Bissery, A ^b,c,d   Wallon, M ^a,e   Cozon, G ^f   Peyron, F ^a,e   Rabilloud, M ^b,c,d  

^a CROIX ROUSSE HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UFR Lyon Nord   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PARASITE ANTIBODY; SPIRAMYCIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MATERNAL AGE; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; COCCIDIOSTATS; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RETROSPECTIVE STUDIES; SPIRAMYCIN; TOXOPLASMA; TOXOPLASMOSIS;

EID: 34147100079     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00311-06     Document Type: Article

References (35)

1. Blais, J., C. Tardif, and S. Chamberland. 1993. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii. Antimicrob. Agents Chemother. 37:2571-2577.
2. Buffolano, W., M. Lappalainen, L. Hedman, F. Ciccimarra, M. Del Pezzo, R. Rescaldani, N. Gargano, and K. Hedman. 2004. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 23:825-830.
3. Cozon, G. J., J. Ferrandiz, H. Nebhi, M. Wallon, and F. Peyron. 1998. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur. J. Clin. Microbiol. Infect. Dis. 17:32-36.
4. Derouin, F. 2001. Anti-toxoplasmosis drugs. Curr. Opin. Investig. Drugs 2:1368-1374.
5. Derouin, F., and C. Chastang. 1988. Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture. Antimicrob. Agents Chemother. 32:303-307.
6. Derouin, F., and C. Chastang. 1989. In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrob. Agents Chemother. 33:1753-1759.
7. Derouin, F., C. Bultel, S. Roze, et al. 2005. Toxoplasmose: état des connaissances et évaluation du risque lié à l'alimentation, p. 1-318. Rapport du Groupe de Travail "Toxoplasma gondii" Agence Française de Sécurité Sanitaire des Aliments. http://www.afssa.fr/frp/afssa/34487-34488.pdf.
8. Diana, J., C. Vincent, F. Peyron, S. Picot, D. Schmitt, and F. Persat. 2005. Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors. Clin. Exp. Immunol. 141:475-484.
9. Dunn, D., M. Wallon, F. Peyron, E. Petersen, C. Peckham, and R. Gilbert. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829-1833.
10. + regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens. Eur. J. Immunol. 36:855-363.
11. Eisen, H. N., and G. W. Siskind. 1964. Variations in affinities of antibodies during the immune response. Biochemistry 3:996-1008.
12. Eyles, D. E., and N. Coleman. 1956. Relationship of size of inoculum to time to death in mice infected with Toxoplasma gondii. J. Parasitol. 42:272-276.
13. Flori, P., L. Tardy, H. Patural, B. Bellete, M. N. Varlet, J. Hafid, H. Raberin, and R. T. Sung. 2004. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin. Diagn. Lab. Immunol. 11:669-674.
14. Goldstein, H. 1995. Multilevel statistical models, 2nd ed., p. 15-40. Kendall's Library of Statistics, London, United Kingdom.
15. Gray, D., and H. Skarvall. 1988. B-cell memory is short-lived in the absence of antigen. Nature 336:70-73.
16. Hedman, K., M. Lappalainen, I. Seppaia, and O. Makela. 1989. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 159:736-740.
17. Hohlfeld, P., F. Daffos, J. M. Costa, P. Thulliez, F. Forestier, and M. Vidaud. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N. Engl. J. Med. 331:695-699.
18. Jenum, P. A., B. Stray-Pedersen, and A. G. Gundersen. 1997. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J. Clin. Microbiol. 35:1972-1977.
19. Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. Jakowlew, M. B. Sporn, and A. S. Fauci. 1986. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855-3860.
20. Lebech, M., D. H. Joynson, H. M. Seite, P. Thulliez, R. E. Gilbert, G. N. Dutton, B. Ovlisen, E. Petersen, et al. 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur. J. Clin. Microbiol. Infect. Dis. 15:799-805.
21. Lefevre-Pettazzoni, M., S. Le Cam, M. Wallon, and F. Peyron. 2006. Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur. J. Clin. Microbiol. Infect. Dis. 25:687-693.
22. Li, S. Y., and D. S. Nelson. 1986. Acetylspiramycin and the immune system. II. Effects on lymphocyte proliferation, lymphokine production, delayed-type hypersensitivity and antibody production. Int. J. Immunopharmacol. 8:657-664.
23. Longo, N. S., and P. E. Lipsky. 2006. Why do B cells mutate their immunoglobulin receptors? Trends Immunol. 27:374-380.
24. Petersen, E., M. V. Borobio, E. Guy, O. Liesenfeld, V. Meroni, A. Naessens, E. Spranzi, and P. Thulliez. 2005. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43:1570-1574.
25. Peyron, F., M. Wallon, and C. Bernardoux. 1996. Long-term follow-up of patients with congenital ocular toxoplasmosis. N. Engl. J. Med. 334:993-994.
26. Remington, J. S., R. McLeod, and G. Desmonts. 2000. Toxoplasmosis, p. 205-346. In J. S. Remington, and J. O. Klein (ed.), Infectious diseases of fetus and newborn infant, 5th ed. Saunders, Philadelphia, PA.
27. Rencuzogullari, E., H. B. Ha, M. Topaktas, A. Kayraldiz, S. Budak, and M. Arslan. 2002. No significant increase in chromosome aberrations and sister chromatid exchanges in cultured human lymphocytes treated with spiramycin. Teratog. Carcinog. Mutagen. 22:51-58.
28. Sensini, A., S. Pascoli, D. Marchetti, R. Castronari, M. Marangi, G. Sbaraglia, C. Cimmino, A. Favero, M. Castelletto, and A. Mottola. 1996. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin. Microbiol. Infect. 2:25-29.
29. + regulatory T-cell subset. Immunology 112:38-43.
30. Stronati, M., L. Bollani, C. Vigano, P. Lanzarini, and G. Rondini. 1998. Application and evaluation of a classification system and case definitions of Toxoplasma gondii infection. Eur. J. Clin. Microbiol. Infect. Dis. 17:67-68.
31. Suzuki, Y., S. Y. Wong, F. C. Grumet, J. Fessel, J. G. Montoya, A. R. Zolopa, A. Portmore, F. Schumacher-Perdreau, M. Schrappe, S. Koppen, B. Ruf, B. W. Brown, and J. S. Remington. 1996. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J. Infect. Dis. 173:265-268.
32. Thulliez, P. 1992. Screening programme for congenital toxoplasmosis in France. Scand. J. Infect. Dis. Suppl. 84:43-45.
33. Wallon, M., L. Kodjikian, C. Binquet, J. Garweg, J. Fleury, C. Quantin, and F. Peyron. 2004. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567-1572.
34. Wegmann, T. G., H. Lin, L. Guilbert, and T. R. Mosmann. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14:353-356.
35. Zenclussen, A. C. Regulatory T cells in pregnancy. Semin. Immunopathol., in press.